BRAIN TUMOUR TREATMENT COSTS:
CHINA vs INDIA vs USA
The same surgery, the same technology, the same drugs — at 30–85% of what you would pay in the USA or Western Europe. Understanding the numbers is the first step to accessing care.
analyticsAt a Glance
- check_circleGBM surgery + RT + temozolomide chemotherapy: ~$15,000–30,000 in China vs $200,000–400,000 in the USA
- check_circleGamma Knife SRS: ~$3,000–6,000 in India and China vs $30,000–80,000 in the USA
- check_circleCarbon ion therapy at SPHIC: ~$50,000–80,000 vs $90,000–140,000 in Germany
- check_circleCancerFax provides patient-specific cost estimates and manages international treatment access
Why Brain Tumour Treatment Costs Differ So Dramatically by Country
Brain tumour treatment costs vary by orders of magnitude across healthcare systems — not because of differences in clinical outcomes, but because of structural differences in how healthcare is priced, insured, and delivered. Understanding these drivers helps patients make informed decisions about where to seek care.
“The surgeon's hands, the radiation beam, and the chemotherapy molecule are the same — it is the billing system, not the medicine, that differs.”
Why the USA Is the Most Expensive
US hospital pricing reflects high administrative overhead, insurer negotiation markups, malpractice insurance, pharmaceutical pricing without government negotiation, and a fee-for-service billing structure. The same brain tumour surgery billed at $80,000 in China reflects staff salaries, not inferior care.
Why China and India Offer Lower Costs
Lower clinical staff salaries relative to the USA, government-subsidised hospital infrastructure, high patient volumes enabling efficiency, and direct self-pay pricing for international patients (without insurer markup) collectively produce 50–85% cost reductions for equivalent high-technology care.
Brain Tumour Surgery Costs: China vs India vs USA
Costs below represent the full episode of care for each procedure — hospital stay, surgeon fees, anaesthesia, ICU, and post-operative monitoring — at leading academic centres.
| Procedure | China (Tiantan / Huashan) | India (Apollo / AIIMS) | USA (Academic Medical Centre) |
|---|---|---|---|
| Craniotomy — glioma resection (standard) | $8,000–15,000 | $5,000–10,000 | $60,000–120,000 |
| Craniotomy — GBM resection (iMRI + 5-ALA) | $15,000–25,000 | $10,000–18,000 | $100,000–180,000 |
| Awake craniotomy — eloquent-region glioma | $18,000–30,000 | $12,000–20,000 | $120,000–200,000 |
| Brain metastasis resection — single large lesion | $8,000–14,000 | $5,000–9,000 | $50,000–100,000 |
| Stereotactic biopsy (diagnostic) | $2,000–5,000 | $1,500–4,000 | $20,000–50,000 |
| Endoscopic pituitary surgery | $6,000–12,000 | $4,000–9,000 | $40,000–80,000 |
Radiosurgery and Radiotherapy Costs: China vs India vs USA
Radiation therapy costs show among the steepest international differentials — Gamma Knife and proton therapy in Asia cost 70–85% less than in the USA.
| Procedure | China | India | USA |
|---|---|---|---|
| Gamma Knife SRS — 1–3 metastases | $3,000–6,000 | $2,500–5,000 | $30,000–60,000 |
| Gamma Knife SRS — 4–10 metastases | $5,000–10,000 | $4,000–8,000 | $40,000–80,000 |
| Gamma Knife SRS — meningioma / AVM | $3,500–7,000 | $3,000–6,000 | $25,000–60,000 |
| Fractionated IMRT — full brain tumour course (30 fx) | $4,000–8,000 | $3,000–6,000 | $30,000–70,000 |
| Proton therapy — full brain tumour course (SPHIC) | $30,000–50,000 | $20,000–40,000 | $100,000–150,000 |
| Carbon ion therapy — full brain tumour course (SPHIC) | $50,000–80,000 | Not available | $100,000–200,000+ |
| Craniospinal irradiation (CSI) — paediatric | $8,000–15,000 | $6,000–12,000 | $50,000–120,000 |
Brain Tumour Chemotherapy and Targeted Therapy Costs
Chemotherapy costs for brain tumours include drug costs plus administration, monitoring, and supportive care — all significantly lower in Asia than in the USA.
| Drug / Regimen | China (per cycle or course) | India (per cycle or course) | USA (per cycle or course) |
|---|---|---|---|
| Temozolomide — concomitant + 6 adjuvant cycles (GBM) | $2,000–5,000 total | $1,500–4,000 total | $15,000–40,000 total |
| Bevacizumab — recurrent GBM (per infusion) | $500–1,200 | $400–900 | $8,000–18,000 |
| PCV (procarbazine + CCNU + vincristine) — oligodendroglioma | $800–2,000 per cycle | $600–1,500 per cycle | $5,000–15,000 per cycle |
| HD-MTX for PCNSL (per cycle incl hospitalisation) | $1,500–4,000 | $1,200–3,000 | $20,000–50,000 |
| Ibrutinib — monthly oral (R/R PCNSL) | $1,000–2,500/month | $800–2,000/month | $12,000–18,000/month |
| ONC201 (Ojemda) — monthly oral (H3K27M DMG) | Expanded access only | Expanded access only | $15,000–25,000/month (approx) |
Total Cost of GBM Treatment: Full First-Year Episode
Glioblastoma requires surgery + concurrent chemoradiation + adjuvant chemotherapy in year one. The total cost differential between the USA and China illustrates the full financial stakes.
- $15,000–35,000GBM full year-1 treatment cost — China (surgery + RT + temozolomide)This covers craniotomy, 30-fraction IMRT/VMAT concurrent with temozolomide, and 6 adjuvant temozolomide cycles at a leading Chinese academic centre.
- $10,000–25,000GBM full year-1 treatment cost — IndiaSimilar scope of care at leading Indian centres (AIIMS, Apollo, Fortis) — slightly lower overall due to drug cost differentials.
- $200,000–400,000GBM full year-1 treatment cost — USAThis reflects average US hospital billing for the equivalent care episode — the majority of which is absorbed by insurance where available, but represents a catastrophic self-pay burden.
Frequently Asked Questions
Common questions from patients evaluating international brain tumour treatment costs.
About Costs and Access
Are these cost estimates reliable for planning?
The figures are approximate benchmarks based on published data and CancerFax partner centre pricing. Actual costs depend on case complexity, procedure duration, ICU requirement, number of MRI scans, and drug doses. CancerFax provides patient-specific cost estimates based on your actual medical records and the treatment plan issued by the receiving centre — before you commit to travel.
Do international health insurance policies cover treatment in China or India?
Coverage varies significantly by policy. Some international and expatriate health insurance policies do cover treatment at accredited hospitals abroad. CancerFax can provide the medical documentation needed for pre-authorisation requests. Self-pay patients benefit from significant savings — the total out-of-pocket cost in China for GBM treatment is typically less than the insurance copay or deductible in the USA.
Are there hidden costs beyond the treatment itself?
Yes — patients should budget for international flights, visa fees, accommodation for themselves and a companion (typically 3–8 weeks for radiation courses), interpreter services, and return travel. CancerFax provides a total trip cost estimate that includes these additional items. In most cases the total cost including travel remains far below equivalent US treatment costs.
Is the quality of care equivalent in China and India?
At the specific high-volume academic centres CancerFax works with, the answer is yes — the surgical and radiation technology is identical to or exceeds what is available at most Western centres. Volume is the critical differentiator: neurosurgeons at Tiantan Hospital or Huashan perform more glioma resections in a month than most Western surgeons perform in a year. CancerFax only refers to centres with documented outcome data and established international patient infrastructure.
More from the Brain Tumour Treatment Resource Library
Explore centre-specific guides and treatment access resources for brain tumour patients.
- ↑ Brain Tumour Treatment — Complete Guide
- Brain Tumour Treatment in China: Tiantan Hospital Beijing and SPHIC
- Getting a Second Opinion on Brain Tumour Treatment Through CancerFax
- Proton and Carbon Ion Therapy for Brain Tumours at SPHIC Shanghai
- Gamma Knife Radiosurgery for Brain Tumours: A Patient Guide
- Brain Metastases: Surgery vs Gamma Knife vs Whole Brain Radiation
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Get a Patient-Specific Cost Estimate
CancerFax provides transparent, centre-specific treatment cost estimates for brain tumour surgery, radiosurgery, particle therapy, and chemotherapy at leading centres in China and India — based on your actual MRI and clinical records.
All costs are approximate estimates based on published data and CancerFax partner centre pricing as of 2024–2025. Actual costs vary by case complexity, surgical duration, and institutional pricing. Contact CancerFax for a patient-specific quote.